rVWF: treatment finally reaches the modern age.

Journal Article

In this issue of Blood, Gill et al describe the results of the first phase 3 clinical trial evaluating recombinant von Willebrand factor (rVWF) for the treatment of hemorrhagic events in all patients with von Willebrand disease (VWD).

Full Text

Duke Authors

Cited Authors

  • Metjian, AD

Published Date

  • October 2015

Published In

Volume / Issue

  • 126 / 17

Start / End Page

  • 1975 - 1976

PubMed ID

  • 26494919

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2015-08-664052

Language

  • eng